Leica Biosystems
Website: http://www.leicabiosystems.com
Member Contact: Dr Ewa Douroux
Position: Marketing Director Asia Pacific
Industry: Medtech & Digital
Company Profile:
Leica Biosystems is a global leader in cancer diagnostics, specialising in anatomical pathology workflow solutions. With a history spanning over 150 years, the company offers a comprehensive portfolio that covers the entire pathology process - from biopsy to diagnosis -aiming to improve diagnostic accuracy and efficiency.
Mission and Vision
Leica Biosystems' mission is "Advancing Cancer Diagnostics, Improving Lives." The company envisions a world where comprehensive insights enhance cancer diagnoses, providing reassurance to patients and enabling timely treatment decisions
Product Portfolio
Leica Biosystems offers an extensive range of products and solutions, including:
• Histology Equipment: Tissue processors, microtomes, cryostats, and embedding centres.
• Staining and Coverslipping: Automated slide stainers and coverslippers.
• Immunohistochemistry (IHC) and In Situ Hybridization (ISH): BOND IHC-ISH instruments and solutions.
• Digital Pathology: Slide scanners, management and integration software, and image analysis tools.
• Consumables: Slides, coverglass, reagents, and other laboratory essentials.
Notably, the company has developed the Aperio GT 450 DX, an automated, high-capacity digital pathology slide scanner designed to enhance digital pathology operations.
Global Presence
Headquartered in Nussloch, Germany, Leica Biosystems operates in over 100 countries, with manufacturing sites and research facilities worldwide, including in the United States, United Kingdom, Australia, and China.
Strategic Partnerships and Acquisitions
Leica Biosystems has engaged in strategic collaborations to advance cancer diagnostics
• Partnership with Bio-Techne's Advanced Cell Diagnostics (ACD): Expanding spatial multiomic solutions for cancer research.
• Collaboration with CellCarta: Accelerating companion diagnostics development in China.
• Acquisition of Cell IDx Inc.: Enhancing multiplex staining panels and imaging services.
Parent Company
Since 2006, Leica Biosystems has been a part of Danaher Corporation, a global science and technology innovator. This affiliation provides Leica Biosystems with access to a broad network of expertise and resources, supporting its commitment to improving diagnostic solutions.
For more information, visit the https://www.leicabiosystems.com/en-au
